BioDrugs
ADIS INT LTD · Switzerland · Est. 1997
ISSN1173-8804eISSN1179-190X
SJR Q1✓ WOS SCIE✓ Scopus / SJR
60
/ 100
Medium Risk
Score Breakdown
✓ WoS SCIE/SSCI+25
✓ Scopus Q1+25
Total60
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
2.29
H-Index
97
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
1.621
Total Works
1,691
Total Citations
48,976
2yr Mean Citedness
6.42
Free JIF alternative
Aims & Scope
An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease .
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q1
SJR Rank
Top 25% in field
General Information
Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published1997
FrequencySix No. A Year 2002-
StatusActive (last: 2026)
Total Publications1,691
Publisher OrgAdis, Springer Healthcare
Submission Info
APC Cost$5,490Above median
Peer Reviewdouble-blind
Review Time—
Acceptance Rate—
OA License—
OA Rate—
Ethics & Quality
COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
📦 Long-term Preservation
CLOCKSS
Think.Check.Submit Compliance
9/12 · 75%
✅
Do you know the journal / publisher?
✅
Does the journal have a website?
✅
Is the ISSN verified?
✅
Indexed in a trusted database?
✅
Peer review process documented?
❌
Follows ethical publishing standards (COPE)?
✅
APC fees clearly disclosed?
✅
Not on predatory/blacklists?
✅
Long-term digital preservation?
❌
Plagiarism detection in place?
❌
Listed in DOAJ (verified OA)?
✅
Primary language documented?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
BiotechnologyQ1
Medicine (miscellaneous)Q1
PharmacologyQ1
Pharmacology (medical)Q1
Subject Classification
Web of Science Categories
ImmunologyOncologyPharmacology & Pharmacy
Scopus Categories
PharmacologyPharmacology (medical)BiotechnologyMedicine (miscellaneous)
Research Topics (OpenAlex)
Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchRheumatoid Arthritis Research and TherapiesCAR-T cell therapy researchImmunotherapy and Immune ResponsesRNA Interference and Gene DeliveryInflammatory Bowel DiseasePharmaceutical Economics and PolicySystemic Lupus Erythematosus ResearchVirus-based gene therapy research
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref